
TIBSOVO® (ivosidenib tablets)
TIBSOVO is a prescription medicine used to treat adults with an isocitrate dehydrogenase-1 (IDH1) mutation with: acute myeloid leukemia (AML): with newly diagnosed AML treated in …
TIBSOVO is indicated for the treatment of adult patients with relapsed or refractory myelodysplastic syndromes (MDS) with a susceptible isocitrate dehydrogenase-1 (IDH1) …
Bile Duct Cancer Treatment | TIBSOVO® (ivosidenib tablets)
TIBSOVO is a prescription medicine used to treat adults with an isocitrate dehydrogenase-1 (IDH1) mutation with bile duct cancer (cholangiocarcinoma) that has spread and who have …
About AML & TIBSOVO® (ivosidenib tablets)
TIBSOVO is a prescription medicine used to treat adults with an isocitrate dehydrogenase-1 (IDH1) mutation with acute myeloid leukemia (AML): with newly diagnosed AML treated in …
Dosing & Side Effects | AML | TIBSOVO® (ivosidenib tablets)
Learn about taking TIBSOVO® alone, or in combination with azacitidine, and possible side effects. See full indication, prescribing information, & Boxed Warning.
AML Treatment Option | TIBSOVO® (ivosidenib tablets)
TIBSOVO is a prescription medicine used to treat adults with an isocitrate dehydrogenase-1 (IDH1) mutation with acute myeloid leukemia (AML): with newly diagnosed AML treated in …
Before taking TIBSOVO, tell your healthcare provider about all of your medical conditions, including if you: • have any heart problems, including a condition called long QT syndrome.
Cholangiocarcinoma Clinical Trial | TIBSOVO® (ivosidenib tablets)
See TIBSOVO® (ivosidenib tablets) clinical trial results in adults with advanced Bile Duct Cancer also known as cholangiocarcinoma. See Full Indication & Prescribing Information. ×
What is Cholangiocarcinoma & TIBSOVO® (ivosidenib tablets)?
TIBSOVO is a prescription medicine used to treat adults with an isocitrate dehydrogenase-1 (IDH1) mutation with bile duct cancer (cholangiocarcinoma) that has spread and who have …
FAQs | CCA | TIBSOVO® (ivosidenib tablets)
See frequently asked questions about TIBSOVO® (ivosidenib tablets) for the treatment of cholangiocarcinoma (CCA). See Full Indication & Prescribing Information.